vs

Side-by-side financial comparison of Everus Construction Group, Inc. (ECG) and Trade Desk (The) (TTD). Click either name above to swap in a different company.

Everus Construction Group, Inc. is the larger business by last-quarter revenue ($1.0B vs $846.8M, roughly 1.2× Trade Desk (The)). Trade Desk (The) runs the higher net margin — 22.1% vs 5.5%, a 16.6% gap on every dollar of revenue. On growth, Everus Construction Group, Inc. posted the faster year-over-year revenue change (33.2% vs 14.3%). Trade Desk (The) produced more free cash flow last quarter ($285.3M vs $23.5M). Over the past eight quarters, Trade Desk (The)'s revenue compounded faster (31.3% CAGR vs 27.1%).

The Trade Desk, Inc. is an American multinational technology company that specializes in real-time programmatic marketing automation technologies, products, and services, designed to personalize digital content delivery to users.

ECG vs TTD — Head-to-Head

Bigger by revenue
ECG
ECG
1.2× larger
ECG
$1.0B
$846.8M
TTD
Growing faster (revenue YoY)
ECG
ECG
+18.9% gap
ECG
33.2%
14.3%
TTD
Higher net margin
TTD
TTD
16.6% more per $
TTD
22.1%
5.5%
ECG
More free cash flow
TTD
TTD
$261.8M more FCF
TTD
$285.3M
$23.5M
ECG
Faster 2-yr revenue CAGR
TTD
TTD
Annualised
TTD
31.3%
27.1%
ECG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ECG
ECG
TTD
TTD
Revenue
$1.0B
$846.8M
Net Profit
$55.3M
$186.9M
Gross Margin
11.6%
80.7%
Operating Margin
6.8%
30.3%
Net Margin
5.5%
22.1%
Revenue YoY
33.2%
14.3%
Net Profit YoY
60.4%
2.6%
EPS (diluted)
$1.09
$0.39

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ECG
ECG
TTD
TTD
Q4 25
$1.0B
$846.8M
Q3 25
$986.8M
$739.4M
Q2 25
$921.5M
$694.0M
Q1 25
$826.6M
$616.0M
Q4 24
$759.6M
$741.0M
Q3 24
$761.0M
$628.0M
Q2 24
$703.4M
$584.5M
Q1 24
$625.7M
$491.3M
Net Profit
ECG
ECG
TTD
TTD
Q4 25
$55.3M
$186.9M
Q3 25
$57.0M
$115.5M
Q2 25
$52.8M
$90.1M
Q1 25
$36.7M
$50.7M
Q4 24
$34.5M
$182.2M
Q3 24
$41.8M
$94.2M
Q2 24
$39.0M
$85.0M
Q1 24
$28.2M
$31.7M
Gross Margin
ECG
ECG
TTD
TTD
Q4 25
11.6%
80.7%
Q3 25
12.6%
78.1%
Q2 25
13.0%
78.2%
Q1 25
11.2%
76.8%
Q4 24
11.4%
81.7%
Q3 24
11.8%
80.5%
Q2 24
12.6%
81.1%
Q1 24
11.9%
78.9%
Operating Margin
ECG
ECG
TTD
TTD
Q4 25
6.8%
30.3%
Q3 25
7.3%
21.8%
Q2 25
7.9%
16.8%
Q1 25
6.2%
8.8%
Q4 24
6.1%
26.4%
Q3 24
7.1%
17.3%
Q2 24
7.3%
16.2%
Q1 24
6.2%
5.8%
Net Margin
ECG
ECG
TTD
TTD
Q4 25
5.5%
22.1%
Q3 25
5.8%
15.6%
Q2 25
5.7%
13.0%
Q1 25
4.4%
8.2%
Q4 24
4.5%
24.6%
Q3 24
5.5%
15.0%
Q2 24
5.5%
14.5%
Q1 24
4.5%
6.4%
EPS (diluted)
ECG
ECG
TTD
TTD
Q4 25
$1.09
$0.39
Q3 25
$1.11
$0.23
Q2 25
$1.03
$0.18
Q1 25
$0.72
$0.10
Q4 24
$0.68
$0.36
Q3 24
$0.82
$0.19
Q2 24
$0.76
$0.17
Q1 24
$0.55
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ECG
ECG
TTD
TTD
Cash + ST InvestmentsLiquidity on hand
$1.3B
Total DebtLower is stronger
$281.5M
Stockholders' EquityBook value
$629.8M
$2.5B
Total Assets
$1.7B
$6.2B
Debt / EquityLower = less leverage
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ECG
ECG
TTD
TTD
Q4 25
$1.3B
Q3 25
$1.4B
Q2 25
$1.7B
Q1 25
$1.7B
Q4 24
$1.9B
Q3 24
$553.0K
$1.7B
Q2 24
$1.5B
Q1 24
$1.4B
Total Debt
ECG
ECG
TTD
TTD
Q4 25
$281.5M
Q3 25
$285.1M
Q2 25
$288.6M
Q1 25
$292.1M
Q4 24
$295.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ECG
ECG
TTD
TTD
Q4 25
$629.8M
$2.5B
Q3 25
$573.0M
$2.6B
Q2 25
$514.4M
$2.7B
Q1 25
$460.2M
$2.7B
Q4 24
$422.6M
$2.9B
Q3 24
$453.3M
$2.6B
Q2 24
$490.0M
$2.4B
Q1 24
$464.3M
$2.2B
Total Assets
ECG
ECG
TTD
TTD
Q4 25
$1.7B
$6.2B
Q3 25
$1.6B
$5.9B
Q2 25
$1.5B
$6.0B
Q1 25
$1.4B
$5.7B
Q4 24
$1.3B
$6.1B
Q3 24
$1.3B
$5.5B
Q2 24
$5.2B
Q1 24
$4.7B
Debt / Equity
ECG
ECG
TTD
TTD
Q4 25
0.45×
Q3 25
0.50×
Q2 25
0.56×
Q1 25
0.63×
Q4 24
0.70×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ECG
ECG
TTD
TTD
Operating Cash FlowLast quarter
$48.2M
$311.6M
Free Cash FlowOCF − Capex
$23.5M
$285.3M
FCF MarginFCF / Revenue
2.3%
33.7%
Capex IntensityCapex / Revenue
2.4%
3.1%
Cash ConversionOCF / Net Profit
0.87×
1.67×
TTM Free Cash FlowTrailing 4 quarters
$90.0M
$795.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ECG
ECG
TTD
TTD
Q4 25
$48.2M
$311.6M
Q3 25
$76.2M
$224.7M
Q2 25
$25.3M
$165.0M
Q1 25
$7.1M
$291.4M
Q4 24
$199.4M
Q3 24
$78.9M
$273.3M
Q2 24
$81.3M
Q1 24
$21.9M
$185.5M
Free Cash Flow
ECG
ECG
TTD
TTD
Q4 25
$23.5M
$285.3M
Q3 25
$65.7M
$158.3M
Q2 25
$12.3M
$119.8M
Q1 25
$-11.4M
$232.3M
Q4 24
$179.2M
Q3 24
$60.9M
$224.6M
Q2 24
$59.1M
Q1 24
$12.6M
$178.2M
FCF Margin
ECG
ECG
TTD
TTD
Q4 25
2.3%
33.7%
Q3 25
6.7%
21.4%
Q2 25
1.3%
17.3%
Q1 25
-1.4%
37.7%
Q4 24
24.2%
Q3 24
8.0%
35.8%
Q2 24
10.1%
Q1 24
2.0%
36.3%
Capex Intensity
ECG
ECG
TTD
TTD
Q4 25
2.4%
3.1%
Q3 25
1.1%
9.0%
Q2 25
1.4%
6.5%
Q1 25
2.2%
9.6%
Q4 24
2.7%
Q3 24
2.4%
7.8%
Q2 24
3.8%
Q1 24
1.5%
1.5%
Cash Conversion
ECG
ECG
TTD
TTD
Q4 25
0.87×
1.67×
Q3 25
1.34×
1.94×
Q2 25
0.48×
1.83×
Q1 25
0.19×
5.75×
Q4 24
1.09×
Q3 24
1.89×
2.90×
Q2 24
0.96×
Q1 24
0.77×
5.86×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ECG
ECG

Commercial$594.5M59%
Utility$203.5M20%
Industrial$82.8M8%
Institutional$66.1M7%
Service And Other$28.4M3%
Transportation$24.2M2%
Renewables$19.8M2%

TTD
TTD

Other$427.2M50%
Non Us$419.6M50%

Related Comparisons